Correlation Between Protalix Biotherapeutics and CohBar

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and CohBar at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and CohBar into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and CohBar Inc, you can compare the effects of market volatilities on Protalix Biotherapeutics and CohBar and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of CohBar. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and CohBar.

Diversification Opportunities for Protalix Biotherapeutics and CohBar

0.49
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Protalix and CohBar is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and CohBar Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CohBar Inc and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with CohBar. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CohBar Inc has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and CohBar go up and down completely randomly.

Pair Corralation between Protalix Biotherapeutics and CohBar

If you would invest  106.00  in Protalix Biotherapeutics on September 13, 2024 and sell it today you would earn a total of  74.00  from holding Protalix Biotherapeutics or generate 69.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy2.33%
ValuesDaily Returns

Protalix Biotherapeutics  vs.  CohBar Inc

 Performance 
       Timeline  
Protalix Biotherapeutics 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Protalix Biotherapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Protalix Biotherapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
CohBar Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CohBar Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, CohBar is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Protalix Biotherapeutics and CohBar Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Protalix Biotherapeutics and CohBar

The main advantage of trading using opposite Protalix Biotherapeutics and CohBar positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, CohBar can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CohBar will offset losses from the drop in CohBar's long position.
The idea behind Protalix Biotherapeutics and CohBar Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Fundamental Analysis
View fundamental data based on most recent published financial statements